Mitochondrial double-stranded RNA accumulates in the brain after midlife, with levels further elevated in Alzheimer's disease where they correlate with cognitive decline. This accumulation reflects disrupted RNA processing machinery and triggers chronic inflammatory signaling, establishing mitochondrial RNA homeostasis as a measurable driver of age-related neurodegeneration.
Key Points
- Mt-dsRNA increases progressively after midlife in normal brain aging
- Elevated mt-dsRNA correlates with cognitive impairment and AD neuropathology
- Disrupted mitochondrial RNA processing precedes inflammatory cascade activation
Longevity Analysis
The mechanism linking mitochondrial dysfunction to neuroinflammation in aging has been theoretically understood, but this work provides specific transcriptomic evidence that mt-dsRNA accumulation is a measurable, quantifiable marker of this transition. The correlation between mt-dsRNA levels and cognitive decline suggests this is not merely an epiphenomenon but a tractable point of intervention. Identifying the upstream causes of impaired RNA processing and the regulatory failures in ubiquitin-dependent signaling creates opportunities to interrupt the inflammatory cascade before significant neurodegeneration occurs, shifting the focus from symptomatic treatment to prevention of the underlying molecular dysfunction.
Original published by Wiley Aging Cell, by Rachel L. Doser, Thomas J. LaRocca .